Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_assertion type Assertion NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_head.
- NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_assertion wasGeneratedBy ECO_0000203 NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_provenance.
- NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_assertion wasDerivedFrom befree-20150227 NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_provenance.
- NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_assertion SIO_000772 20533549 NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_provenance.
- NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_assertion evidence source_evidence_literature NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_provenance.
- NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_assertion description "[NUDT2 immunoreactivity was detected in 78% of DCIS and 63% of IDC, and NUDT2 mRNA level was significantly higher in DCIS or IDC than non-neoplastic breast.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240296.RAeFS20NgL-BCK0LnGh0ebJrp5yxr55YCKXjdL4PC6BHE130_provenance.